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Abstract 
Background 
Studies indicate suboptimal patient understanding of the capabilities, lifestyle 
implications, and risks of LVAD therapy. This paper describes the development 
methodology and pilot-testing of a decision aid for Left Ventricular Assist Device 
(LVAD) placement, combining traditional needs-assessment with a novel user-
centered approach.   
Methods and Results 
 We developed the decision aid in line with the Ottawa Decision Support 
Framework (ODSF) and the International Patient Decision Aids Standards 
(IPDAS) for ensuring quality, patient-centered content. Structured interviews 
were conducted with patients, caregivers, candidates for LVAD treatment, and 
expert clinicians (n=71) to generate content based on patient values and 
decisional needs, and providers’ perspectives on knowledge needs for informed 
consent. The aid was alpha tested through cognitive interviews (n=5) and 
acceptability tested with LVAD patients (n=10), candidates (n=10), and clinicians 
(n=13). Patients, caregivers and clinicians reported they would recommend the 
aid to patients considering treatment options for heart failure. Patients and 
caregivers agreed that the decision aid is a balanced tool presenting risks and 
benefits of LVAD treatment and generating discussion about aspects of heart 
failure treatment that matter most to patients. 
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Conclusion 
We identified gaps in knowledge about heart failure treatment options, including 
diagnosis, decision-making, surgery, post-operative maintenance and lifestyle 
changes. Challenges included presenting risks and benefits for informed decision 
making without frightening patients and circumventing reflection, and balancing 
an emphasis on LVAD with other alternative treatment options like comfort-
directed palliative and supportive care. 
Keywords 
Left ventricular assist device; heart failure treatment; decision aid; shared 
decision-making 
 
Background 
Decision aids are paper- or electronic-based tools that help patients make 
treatment choices, particularly where the optimal course of treatment is uncertain 
and preferences guide the treatment selection. Decision aids help increase 
patient and caregiver knowledge, decrease decisional conflict and regret, and 
increase accurate risk perceptions and the match between values and choice1. 
Whether and how patient decision aids (PDAs) help patients and caregivers 
reach informed and preference-congruent decisions depends on their quality, as 
defined by The International Patient Decision Aid Standards (IPDAS) and their 
user-centeredness. While many decision aids claim to be patient-centered, few 
studies document the process and “best practices” by which PDAs come to be 
centered in patient and caregiver perspectives, beliefs, and value preferences2, 3.  
This paper describes the development methodology of a decision aid to help 
patients and caregivers evaluate options for treating end-stage heart failure, 
particularly those eligible to receive a Left Ventricular Assist Device (LVAD). Our 
primary goal is to describe the systematic and rigorous manner in which this aid 
was developed so that clinicians considering using it in their clinical flow would 
know its evidence-based foundation, and to encourage replicability by other 
researchers who wish to develop decision aids for other cardiology-related 
treatment options.  
We consider decision aids particularly important for LVAD placement because 
the decision about device placement is especially value-laden and preference-
sensitive due to the complex trades-offs and burdens associated with the device4, 
5. Aside from the device’s high cost (among the most expensive interventions in 
medicine, at $500,000-$1.4 million per quality-adjusted-life-year6, 7), additional 
decision-making considerations include: duration and quality of life, convenience, 
preservation of bodily integrity, body-image, limitations and changes in activities 
of daily living and functional or exercise capacity, risk of death or other adverse 
events, and impact on familial and other relationships8, 9.  
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Aside from value tradeoffs, studies indicate poor patient understanding, even 
while the number of LVAD implantations continues to dramatically increase10. 
Recognizing these issues, the American Heart Association (AHA) emphasized 
the “crucial” need for improved informed consent processes, increased shared 
decision-making, and development of decision aids not tied to any particular 
device company4. Other researchers, notably Witteman et al.3, have called for a 
user-centered approach to decision aid development. 
We responded to these calls by developing a patient-centered aid for decision-
making about LVAD placement for advanced heart failure. Drawing from mixed 
qualitative and quantitative methods across the fields of medical anthropology, 
ethics and decision science, we outline a methodology for an inductive and 
iterative discovery of user-centered decisional-needs. 
Methods 
Step 1. Identify the Theoretical Framework 
The development of our decision aid is theoretically grounded in the Ottawa 
Decision Support Framework (ODSF) and practically guided by IPDAS criteria for 
ensuring quality, patient-centered content. The ODSF is an evidence-based, mid-
range theory for guiding patients to make health decisions, incorporating insights 
on decision-making from general psychology11, social psychology12, decision 
analysis13, decisional conflict14, social support15, 16, and economic concepts of 
expectations and values17. The framework uses a three-step process to 1) 
assess client and practitioner determinants of decisions to identify decision 
support needs; 2) provide decision support tailored to client needs; and 3) 
evaluate the decision making process and outcomes 18.  
 ODSF also provides a development toolkit for presenting information about the 
condition, options, risks and benefits, values clarification, and optional elements 
such as narratives/testimonials. Conceptually, we group the IPDAS/ODSF steps 
together into 1) Formative Research (Steps 1-5, see Table 1); 2) Drafting the 
PDA (Step 6); and 3) Pilot Testing/Finalizing the PDA (Steps 7-8). We present 
them in this order below and in the Results. 
Approval was granted by the Institutional Review Boards (February 2014) at our 
own institution and partner hospital for each phase of the research undertaken 
with the aim of creating a user-centered and clinically-informed decision aid to be 
tested for effectiveness in clinical practice. The research, including patient and 
clinician stakeholder engagement, data collection, decision aid drafting, cognitive 
testing, and usability and alpha testing occurred from February 2014 to May 2015 
(see Table 1). All participants, including patient stakeholders, provided voluntary 
and informed consent to participate. 
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Formative Research 
 
Step 2. Convene Expert Panel 
We began our research with the formation of an expert panel (Table 1, Step 2) to 
help with the process of “scoping,” or describing the health condition (advanced 
heart failure), stating the range of decisions to be considered, and specifying the 
target audience. In addition to clinical experts, three patient experts who have 
already undergone decision-making and LVAD treatment were selected as 
members of our development team after recruiting via the “LVAD Recipient 
Support Group” Facebook site and through the our partnering hospital’s LVAD 
Support Group. Applicants were screened and selected based on: (1) the 
richness of their answers to questions about why they want to participate, (2) 
what they know now that they wish they knew before LVAD placement, and (3) 
their level of involvement with other heart failure organizations as an indicator of 
broader patient perspective. To select our patient partners, we used adapted 
Patient Centered Outcomes Research Institute (PCORI) advisory-panel selection 
criteria19 for scoring (i.e., experience with specific disease/health condition, 
functional ties and experience with particular stakeholder/support group, and 
degree to which their experience and background could improve our work) along 
with diversity considerations. Convening the expert panel and patient consultants 
took about one month (July 2013).  
Regular bi-weekly meetings were held with core members of the expert panel, 
comprised of four key clinical experts selected, including two cardiothoracic 
surgeons, one heart failure cardiologist, and an ethicist specializing in transplant 
ethics. Other clinicians, including surgeons, cardiologists, LVAD coordinators, 
nurses, social workers and ethicists at our partnering hospitals were also 
sometimes present. 
Step 3. Literature Review of Decisional Needs    
We conducted an extensive literature review for 5 purposes: (1) to evaluate 
existing knowledge about user decisional needs; (2) to familiarize ourselves with 
any available decisional support tools relevant to advanced heart failure 
treatment; (3) to identify theoretical frameworks to confirm the relative quality and 
utility of the ODSF; (4) to confirm the need for a decisional aid for current-
generation LVAD treatment (e.g. Thoratec’s HeartMate II and HeartWare’s 
HVAD), and (5) to review important considerations for LVAD placement, 
including patient selection criteria and facets of information for a robust informed 
consent process (e.g., quality of life determinants, predictive models, 
psychological adjustment). We searched PubMed, PsycInfo, CINAHL databases, 
the Cochrane Library and the existing IPDAS literature using terms such as 
“LVAD,” “decision-aid,” “decisional needs,” “decisional support,” etc.. 
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Step 4. Assess User Needs 
We then conducted semi-structured, in-depth qualitative interviews with patients, 
caregivers, candidates, and decliners of LVAD treatment, in order assess users’ 
decisional needs from their own perspectives. These questionnaires are 
available in the supplementary materials from other publications20, 21. We also 
conducted in-depth interviews at this stage with clinicians, including cardiologists, 
cardiothoracic surgeons, LVAD clinic team coordinators, and palliative and 
supportive care specialists involved in shared decision-making, to better 
understand patient informational and decisional needs from a clinical outlook. 
Separate interview protocols were used for each interviewee type. Interview 
domains across types included perceptions of options, outcomes, and 
probabilities; values in decision-making; degree of decision-making difficulty and 
factors contributing to difficulty; usual and preferred decision making roles; 
decisional barriers and facilitators.  A technique called “progressive focusing” 
was used whereby interview questions were modified iteratively throughout the 
process of data collection, so that question items with diminishing informational 
returns were gradually replaced by questions eliciting new information from 
patient narratives22. 
Step 5. Collate the Clinical Evidence for Treatment Options 
Information gained in steps 1-4 was crucial for understanding user-centered 
preferences and clinical criteria for informed decision-making regarding treatment 
option (see Results), paving the way for a robust patient- and caregiver-centered 
presentation strategy. Specifically, we drew insights from a literature review that 
included data from the INTERMACS registry, the largest annual repository of 
statistics about LVADs gathered from participating hospitals across the U.S. and 
published on a quarterly and annual basis, the source most trusted by our expert 
panel. We summarized clinical evidence relevant to LVAD and alternative 
treatment options by cross-referencing INTERMACS data with clinical trial 
outcomes data for non-pulsatile LVAD therapy (including both Destination 
Therapy and Bridge-to-Transplant) found in systematic reviews identified through 
the PubMed, PsycInfo, CINAHL databases, and the Cochrane Library. We 
excluded articles that do not present evidence-based practice guidelines or 
original, peer-reviewed, empirical research. 
We collated these outcomes data with information from the in-depth interviews 
with clinicians and hospital staff used to assess user needs, and ongoing input 
from our expert panel and patient consultants to cumulatively generate a list of 
alternative treatment options with associated risks and benefits for inclusion in 
the decision aid. 
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Step 6. Drafting the PDA 
Incorporating information from all phases of formative research above, we 
developed a first draft of the decision aid, following IPDAS quality indicators 
(Table 2) 23. These criteria provided guidance for the content, format and 
evaluation of the decision tool. Working closely with an experienced design team, 
we collaboratively planned the decision aid outline, including the ordering and 
aesthetic considerations involved in information presentation. For example, we 
considered whether patients would prefer to learn about the device itself first 
before hearing other patients’ experiences or outcome statistics, etc. We also 
considered layout and formatting issues, like whether the PDA should be all one 
booklet or contain separate sheets or “pull-outs” with information to keep on-hand 
(e.g. resources for patients, considerations for caregivers, etc.) that can easily be 
updated as clinical evidence changes. During this time, we also held photo and 
video shoots with patients and caregivers in their homes and in hospital settings 
to generate footage and imagery of patient experiences with LVAD decision-
making and treatment for inclusion in the decision aid and accompanying 
website.  
This phase also included the development of an LVAD Knowledge Scale for 
inclusion in the decision aid as a tool for patients and caregivers to assess their 
knowledge about LVAD therapy24. Knowledge about treatment options is 
considered to be one of the primary components of a high-quality decision25 and 
one of the standard set of outcomes used to assess decision aids1, 26. Question-
items for the scale were developed from questions and decisional needs that 
emerged from participants and clinician recommendations about essential 
components of informed decision-making for LVAD therapy. Development and 
validation of the LVAD Knowledge Scale is described in another publication24. 
Step 7. Alpha Testing 
To test users’ perceptions and understanding of the content, relevance and 
readability of the decision aid, we first conducted cognitive interviews or “think 
aloud” exercises with patients, caregivers, and clinicians who were asked to give 
qualitative feedback on each section of the decision aid. Changes were made 
iteratively based on consensus in feedback. Next, we administered validated 
quantitative questionnaires to evaluate patients’, caregivers’ and clinicians’ 
perceptions of the decision aid’s acceptability 27, covering aspects of each 
section’s usability, likability, informative effectiveness, audience appropriateness, 
format, timing, range of content, and any open-ended suggestions for 
improvement from participants. 
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Table 1: Development process of Deciding Together Using the IPDAS and ODSF 
Frameworks  
 
Step 1: Identify the theoretical framework 1/14 
Framework: IPDAS 
Objectives: To review alternative theoretical frameworks for decisional support. 
Methods: Literature review. 
Outcome: The Ottawa Decisional Support Framework was confirmed against competing 
decisional frameworks for its high quality standards and frequency of implementation. 
Step 2: Convene an expert panel 2/14 
Framework: IPDAS / ODSF 
Objectives: Incorporate expert insights and feedback on patient/caregiver needs, content and 
format of PDA, implementation plans and feasibility 
Methods: Expert consensus (face-to-face meetings) 
Outcome: 
(1) Four key clinical experts selected, including two cardiothoracic surgeons, one heart failure 
cardiologist, and an ethicist specializing in transplant ethics (biweekly face-to-face meetings) 
(2) Other clinicians, including surgeons, cardiologists, LVAD coordinators, nurses, social workers 
and ethicists consulted intermittently for in-depth interviews about patient decisional needs and to 
provide feedback on PDA materials (face-to-face meetings, online SurveyMonkey feedback about 
acceptability) 
(3) Three patient experts selected to provide feedback on personal knowledge and experiences, 
and to vet PDA content and evaluate acceptability and usability (individual and face-to-face 
meetings) 
Step 3: Review the literature 2/14 
Framework: IPDAS 
Objectives:  
(1) To assess existing information about LVAD patient population decisional needs 
(2) To assess needs and parameters for decisional aid. 
Methods: Review of decisional support literature. 
Outcome: Literature revealed a lack of field-tested and clinician-reviewed decisional support tools 
for LVAD candidates,  
Step 4: Assess users’ needs 3-9/14 
Framework: IPDAS / ODSF 
Objectives: 
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(1) Assess patient and caregiver decisional needs to tailor decisional support 
(2) Assess clinicians’ perceptions about patient decisional needs, including content, format and 
timing of PDA administration. 
Methods: Individual in-depth interviews with patients, caregivers, LVAD decliners, and clinicians 
Outcome: 
(1) 15 LVAD candidates, 15 patients, 15 caregivers, 15 LVAD decliners and 11 
clinicians involved in LVAD care were interviewed. 
 
(2) All interviewees identified decisional and support needs, and their guiding values. Results 
were analyzed thematically across participants and served as key messages/content for the PDA.  
(3) Interactive paper- and computer-based formats were preferred by all interviewed subgroups. 
Step 5: Collate the clinical evidence for treatment options 10-11/14 
Framework: IPDAS / ODSF 
Objectives: To review and provide a balanced summary of all treatment options in the PDA 
Methods: 
(1) Literature review of national clinical guidelines, and interviews with clinicians about 
treatment alternatives. 
(2) To gather clinical and statistical data on LVAD outcomes to portray in risks/benefits section of 
the PDA 
 
Outcomes:  
Statistics on LVAD risks, benefits and outcomes were selected to present to our expert panel for 
possible inclusion in the PDA. Clinical experts and the literature confirmed that for patients for 
whom medical management no longer works, LVAD treatment, transplant, and palliative care are 
the three predominant treatment options for end-stage heart failure.  
Step 6: Drafting the PDA 11/14-1/15 
Framework: IPDAS / ODSF 
Objectives: Develop the first draft of the PDA, incorporating interview data and expert feedback 
Methods: 
(1) Integration of IPDAS-guided content from literature reviews, in-depth interviews, and face-to-
face meetings 
(2) Work closely with the design team to draft a version of the PDA incorporating patient 
knowledge needs and preferences, clinical relevancy and aesthetic appeal. 
(3) Photo and video shoots with patients and caregivers in both home and hospital settings to 
generate images and footage for the PDA. 
Outcomes: A working draft was created, consisting of 7 main tabs, 6 stand-alone, interactive pull-
out sections, numerous photos and supplementary video for the website. 
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Step 7: Alpha Testing of the PDA 1-4/15 
Framework: IPDAS / ODSF 
Objectives: 
(1) Test for cognitive understandings of relevance and readability 
(2) Test for acceptability to receive specific feedback on content, layout, usability, and readability 
(3) Evaluate preliminary PDA content and format, including both the paper-based and web-based 
(e.g. video) PDA content. 
Methods: 
(1) Interviews for cognitive testing and validated instruments for acceptability testing 
(2) Iterative process of review and modification with feedback from patient experts and clinicians. 
Outcomes: The PDA went through 5 iterations and consensus on a final draft was reached by the 
researchers and patient/clinician experts. Cognitive testing was done with 5 patients. Acceptability 
testing was done with 10 patients, 10 candidates, and 13 clinicians.  
Step 8:  Finalize the PDA 5/15 
Framework: IPDAS 
Objectives: Final integration of feedback from formative research & alpha testing to construct 
final content for PDA. 
Methods: Meetings with researchers and team members to consolidate feedback and make final 
content and format decisions. 
Outcomes: Final PDA developed and ready for clinical trial.  
 
Results 
All results from the above phases were merged to formulate the content and 
format of the decision aid, following the IPDAS Collaboration Framework (Table 
2). We describe results of each step outlined above in the same order below. 
Formative Research 
Step 2. Convene Expert Panel 
Our expert panel provided intermittent feedback on the content and format of the 
tool to meet informed consent standards and to integrate with standard 
educational procedures and clinical workflow. Our experts highlighted 
suggestions for providing a balanced presentation of LVAD versus other 
treatment options (e.g. comfort-directed care), and how best to target a non-
clinical audience without leaving out information important to decision-making. 
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Table 2: Development of the LVAD Decision Aid Content using the International 
Patient Decision Aids Standards Collaboration (IPDAS) Framework 
 
1. IPDAS Criteria: Providing information about options 
Domains: Development (content) 
1. Findings from the needs assessment helps to identify patient-relevant values and preferences 
for decision-making, and clinical criteria for informed decision-making. 
2. Overview information about options is presented in sections: 
a.    “About LVAD,” “LVAD Surgery,” and “Living with an LVAD” 
b.    “About Palliative and Supportive Care” 
 
2. IPDAS Criteria: Presenting probabilities 
Domains: Development (content) 
1. The “LVAD by the Numbers” section uses pictographs (best practice) to present facts and 
figures regarding risks and benefits, based on expert input from clinicians. Information 
includes: 
a. Number of LVAD patients and their longevity 
b. Likelihood of LVAD patients receiving heart transplants 
c. Rate of complications and re-hospitalization after LVAD (30 days and 1 year) 
d. Risks (top 5) of LVAD surgery  
 
3. IPDAS Criteria: Clarifying and expressing values 
Domains: Development (content) 
1. Patient and caregiver values in decision-making are addressed in the “LVAD and Your 
Values” section, helping users to clarify their values regarding: 
a. Extension of life 
b. Bridging to transplant 
c. Improving heart failure symptoms and quality of life and mobility 
d. Time to rehabilitation 
e. Avoidance of complications like bleeding, infection and stroke 
f. Dealing with daily lifestyle changes and maintenance 
g. Increasing dependence on others and affecting caregiver’s lifestyle 
h. Dealing with LVAD-related expenses 
i. Using a worksheet, patients explicitly rate how important each factor is in their decision. 
 
4. IPDAS Criteria: Guiding/coaching in deliberation and communication 
Domains: Development (content) 
1. In line with IPDAS quality standards, the PDA includes a section on “How to Decide,” 
designed to: 
a. Encourage shared decision-making 
b. Prepare patients and caregivers to identify their own values 
c. Provide overview of information needed to make informed decisions 
d. Compare options, including benefits and risks, of receiving versus declining LVAD treatment 
(in “best practice” side-by-side format). 
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5. IPDAS Criteria: Disclosing conflicts of interest 
Domains: Development (process) 
1. Collaborators in the creation of the PDA are presented in the About this Decision Aid 
document on the accompanying website lvaddecisionaid.com 
 
 
6. IPDAS Criteria: Balancing the presentation of options 
Domains: Development (content/format) 
1. The PDA provides balanced content by: 
a. Elaborating definitions, risks and benefits of palliative care as an alternative 
b. Presenting LVAD and its alternatives with equal, unbiased tone and in the same font and 
format 
c. Side by side presentation of benefits vs. risks challenges of receiving LVAD vs. not receiving 
LVAD` ` 
2. The balance of information was assessed in acceptability testing among patients, caregivers 
and clinicians. 
 
7. IPDAS Criteria: Using plain language (readability) 
Domains: Development (format) 
1. The PDA used “plain language” as assessed during cognitive interviewing and acceptability 
testing with patients, caregivers and clinicians. 
 
8. IPDAS Criteria: Basing information on up to date scientific evidence 
Domains: Development (content/process) 
1. All clinical information was based on most recent findings about LVAD therapy as reported in 
the continuously updated INTERMACS database and systematic reviews. 
2. Survival statistics and outcomes/risk data were verified by clinical experts from our team. 
 
9. IPDAS Criteria: Establishing effectiveness 
Domains: Development (evaluation) 
1. The PDA has undergone pilot alpha testing, including: 
a. Cognitive Testing 
b. Acceptability Testing 
2. The PDA will undergo beta testing, including: 
a. Randomized controlled trial of decision aid efficacy 
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We met with our patient partner representatives (n=3) in scheduled meetings 
every 1-2 months in which they helped to provide subjective feedback on the 
relevance of decision aid content and format at each stage of the decision aid 
development process. The most valuable information we learned from our patient 
consultants are first-hand experiences about what they wished they had known 
before deciding on LVAD implantation. Their personal narratives and suggestions 
helped us to further generate and refine content for the PDA. Two out of our 
three partner representatives also participated in alpha testing. 
Step 3. Review the Literature 
 A review of the literature revealed that (1) There is little work on decision needs 
of heart failure patients, and few guidelines for informed consent for LVAD 
placement;28-30 (2) No patient decision aid currently exists for LVAD placement 
for advanced heart failure, despite the calls of AHA; (3) Only 50% of decision 
aids are field-tested;31
 
(4) A recent systematic review of 84 decision aids found 
that only a handful have been reviewed by a clinician not involved in the 
development process, even though the IPDAS Collaboration recommends 
this;31(5) Clinician involvement in field-testing is a crucial but rarely completed 
step in the development of decision aids.32 
Step 4. Assess Users’ Needs 
Results from a total of 60 in-depth interviews with patients (n=15), caregivers 
(n=15), LVAD candidates (n=15) and decliners (n=15) form the centerpiece of 
our understanding of user decisional needs. Patients were NYHA Class III and 
IV, between 30-85 years old and capacitated, with an acceptable surgical 
risk/benefit ratio for LVAD implantation and with good psychosocial support, 
coping mechanisms, and financial resources, as determined by clearance from 
the LVAD/transplant social worker. Our sample also reflected the gender (80% 
male, 20% female) and age (45% 40-59, 45% 60-79) distribution in LVAD 
placement33.
 
Qualitative interviews were completed from March to August 2014 
(5 months). A majority (n=52) of interviews was conducted by members of our 
research team in private rooms of the LVAD clinic, while a minority (n=8) was 
conducted over the phone based on patient preference and availability. 
Interviews were audio-recorded, transcribed, and analyzed collaboratively using 
the well-established method of Grounded Theory34 method of analysis in 
ATLAS,ti, a computer-assisted qualitative data analysis software.  
While findings from this phase of formative research are elaborated elsewhere20, 
in summary they reveal a prevailing tendency to make decisions about LVAD 
therapy reflexively among patients and caregivers, who largely believe that they 
do not have a choice about whether to get an LVAD, given their values regarding 
life extension, family and mobility. Patients and caregivers expressed a 
preference for shared decision-making with their clinical team, as well as having 
an informed/involved caregiver and hearing stories from other patients with the 
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device when deciding. Over half of patients demonstrated lack of clarity 
regarding LVAD therapy in relation to heart transplant. Decliners in particular 
believed that LVAD placement would impact their ability to receive a transplant, 
and expressed a strong preference for waiting to surgically intervene until they 
felt sufficiently “sick enough.” Our decision aid aimed to improve on these 
elements and answer the specific informational needs of patients. 
Step 5. Collate the Clinical Evidence for Treatment Options 
Our review provided clinical statistics for inclusion in the decision aid (see LVAD 
by the Numbers tab of the decision aid) in order to provide patients and 
caregivers with an accurate representation of risks and benefits of LVAD 
treatment. Our clinical expert panel along with IPDAS requirements for evidence 
presentation helped us to identify the core clinical evidence to include in the 
decision aid.  
In-depth interviews with clinicians (n=11) during the formative research phase 
also provided a distinct perspective about what patients need to know from a 
clinical standpoint in order to make an informed decision. These clinicians 
included cardiologists (n=3), cardiothoracic surgeons (n=2), LVAD coordinators 
(n=2), a hospital financial advisor (n=1), clinical social workers (n=2), and a 
clinical bioethicist (n=1). These interviews highlighted the need for patients to 
have realistic expectations about risks and benefits of LVAD treatment (both 
short-term/immediately post-operative and longer term), to recognize the 
importance of post-operative maintenance behaviors and support, and to better 
understand of the role of LVAD in relation to transplant.   
Step 6. Drafting the PDA 
Based on these key messages from patients, our clinical expert feedback, the 
IPDAS guidelines for decision aid content and presentation of information, and 
the summary of clinical evidence, we drafted the decision aid using a 
“storyboard,” a series of short sections comprising the preliminary informational 
content of the decisional aid. All storyboards were reviewed with our clinician 
experts for medical accuracy. We then worked with our design team to generate 
and organize the content, including all the main decision aid components and 
script (e.g., what is a LVAD, risks and benefits of LVADs, values clarification 
exercise, etc.). We followed IPDAS guidelines for reaching audiences with lower 
health literacy using pictographs, frequencies, and narratives. 
In addition to drafting the print and online versions of the tool, we also worked 
with the design team to host a photo and video shoot of selected participants 
whose patient and caregiver narratives are featured in the decision aid. These 
shoots aimed to showcase patients living with the device, and took place over the 
course of multiple days on-site in patients’ homes and neighborhoods, as well as 
at our partner hospital where patients regularly interact with their healthcare 
team. The footage includes glimpses of and variation in patients’ experiences 
  
 
 
The VAD Journal: http://dx.doi.org/10.13023/VAD.2016.01    Page 14 of 21 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
and challenges living with an LVAD (e.g. caring for the driveline; logistics of 
cooking meals and cleaning house, achieving mobility to travel or spend time 
with loved ones, etc.). Photos also illustrate many of the important steps of the 
decision-making process, including talking to other clinicians and patients with 
LVADs. 
Step 7. Alpha Testing 
Cognitive interviews were conducted with 3 patients and 2 candidates to assess 
content clarity and readability of the entire decision aid. Cognitive interviewing 
involves “think aloud” exercises where the patient is asked to review the 
storyboards and describe in their own words the meaning of the information. 
During this process, changes in wording, informational content, and format were 
suggested to ensure the messages in the aid are being communicated clearly. 
The decision aid was then tested for acceptability among 10 patients, 10 
candidates, and 13 clinicians (Table 3). Findings from this phase of testing 
indicated an overwhelmingly positive response to the decision aid, with 100% of 
patients/candidates saying they would recommend the aid to other people 
considering treatment options for heart failure, and 92% of clinicians saying they 
would recommend the aid to patients making a decision. Likewise, 100% of 
clinicians and patients/candidates agreed that the decision aid would help 
patients understand more about the risks and benefits of LVAD treatment, and to 
think about what aspects of heart failure treatment matter most to patients. Only 
5% of patients/candidates felt that they had unanswered questions after reading 
the decision aid, and 70% of patients/candidates reported learning something 
new from the aid that they did not know before. Acceptability testing confirmed 
that the decision aid was appropriately targeted to its intended audience and 
reading level. A total of 95% of patients/candidates said they could relate to the 
people portraits in the patients’ stories and photographs, and 100% said they 
could easily understand the information they were presented with. 
In terms of format, participants shared their preferences for print with 
supplementary online delivery over other formats. With regard to distribution 
timing, a majority (55%) of candidates preferred to receive the PDA when visiting 
a local heart doctor before referral to an LVAD program, and only a quarter 
(25%) preferred to receive it after being evaluated and offered LVAD therapy. 
This phase of testing highlighted a need to further clarify and develop certain 
sections (e.g. elaborate on palliative and supportive care) for a more informed 
and balanced presentation of alternative treatment options. While 
patients/candidates (100%) and clinicians (92%) agreed that the decision aid 
covered both positive and negative aspects of LVAD treatment, a majority of 
patients felt the decision aid “clearly” (50%) or “slightly” (20%) favored LVAD 
treatment.  
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Table 3 
Combined UA Testing of DA (n=20) and Supplemental Videos (n=10): 
 
 
Subject Type 
Number of 
Participants 
Average 
Age, Range 
Ratio Male 
to Female 
%White   
%Black   
%Hispanic 
Ratio 
of BTT 
to DT 
D
e
ci
si
o
n
 A
id
 (
n
=2
0
) 
LVAD 
Patients 
10 
59 years, 
(26-79) 
7 M : 3 F 
70% White 
30% Black    
0% Hispanic 
4 BTT :  
6 DT 
LVAD 
Candidates  
10 
59 years, 
(45-70) 
6 M : 4 F 
50% White     
40% Black      
10% Hispanic 
N/A 
Su
p
p
le
m
e
n
ta
l V
id
e
o
s 
(n
=1
0
) 
LVAD 
Patients 
5 
61 years, 
(56-69) 
3 M : 2 F 
60% White 
40% Black    
0% Hispanic 
2 BTT :  
3 DT 
LVAD 
Candidates  
5 
57 years, 
(45-68) 
4 M : 1 F 
60% White     
20% Black 20% 
Hispanic 
N/A 
Note: Clinician participants (n=13) are not featured in the table. 
 
The PDA took an average of 59 minutes (~1 hour) to fully review, with 95% of 
participants voluntarily reading the aid from cover to cover. A total of 75% of 
patients and candidates thought the length was “about right.” The final version of 
the decision aid can be found at www.lvaddecisionaid.com. 
Step 8. Finalize the PDA: Plans for trial testing 
The decision aid will be further tested in a multi-site randomized trial to take 
place (over one year beginning June 2015) across five cardiovascular hospitals 
across the country, including our main partner hospital. In addition to testing for 
effects of the aid on decision-making, a crucial aspect of trial planning and 
execution is to learn about the clinical work flow dynamics of other hospitals 
through our research collaborations, and to gather insights about effective versus 
non-effective distribution and dissemination strategies for the future. The main 
outcome measures for the trial are: LVAD knowledge, clarity about transplant 
status/eligibility, affective forecasting regarding life with LVAD, shared decision-
making, decisional conflict, values clarity, preparedness for decision-making, 
satisfaction with decisional process, and decision satisfaction/regret.  
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Discussion 
We created a decision aid that presents outcomes, risks, projected experiences, 
and uncertainties about left ventricular assist device (LVAD) placement in a 
balanced way to help patients make informed and value-based decisions about 
placement.35 Combining IPDAS and ODSF guidelines at each stage of decision 
aid development enabled us to ensure that the development of decision aid 
content and format not only answers patient/caregiver questions, but is also 
guided by an explicit quality-driven framework that is replicable by other 
researchers seeking to develop similar decision aids.  
A primary goal for decision aid development was to integrate clinical expertise 
with user preferences, characteristics and values to ensure relevance and 
acceptability. Therefore, we sought to appeal to a wide variety of stakeholders 
(patients, caregivers, candidates, decliners) so that the tool could be broadly 
acceptable and patient-centered.  In line with our findings about decisional 
needs, we paid special detail to clarifying how LVAD treatment affects transplant 
status, along with lifestyle and technical issues, where patients have the most 
informational needs. Taken together, findings from outcomes data as well as 
from LVAD patients, candidates and clinicians helped us to tailor the content of 
the decision aid in ways that address users’ perceptions and preferences, while 
clarifying potential misconceptions about the range of available treatment options 
for heart failure and educating patients about key aspects necessary for 
providing informed consent or refusal for LVAD treatment. 
We consulted clinical experts both inside and outside of our expert panel to 
provide feedback on how best to integrate the decision aid into clinical flow. 
Eliciting input from clinicians who were not involved in the development process 
helped to reduce bias by providing an independent review of our decision aid, as 
well as to make the aid more generalizable to other LVAD patient populations. 
While over 500 patient decision aids have been developed worldwide36, a recent 
systematic review of 84 decision aids26 found that only a handful have been 
reviewed by a clinician not involved in the development process, despite IPDAS 
recommendations.
  
A majority of the challenges we faced during the development process were 
related to choices about information content. Our goal was to offer a balanced 
presentation of risks and benefits without overwhelming patients, while at the 
same time, satisfying clinical experts who requested that patients and caregivers 
be presented with realistic expectations about outcomes and common 
complications. Under the advice of our clinical experts, we erred on the side of 
highlighting risks in order to ensure informed decision-making. 
 
An additional challenge was maintaining a balanced presentation of information 
about LVAD treatment in relation to other treatment options. Given that the 
decision aid focuses on LVAD treatment, other treatment options were not as 
deeply elaborated. Working closely with experts in palliative and supportive care 
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helped us to maximize information about alternatives for addressing advanced 
heart failure to ensure informed decision-making across a full range of treatment 
choices. We also took into account perspectives from decliners of LVAD 
treatment in order to acknowledge values influencing LVAD refusal. The content 
of the decision aid is overall positive, but this is in keeping with patients’ and 
caregivers’ perspectives, as reflected through our empirically-derived interviews. 
A principal reason why we engaged in alpha-testing was to elucidate clinicians’ 
perspectives on how the tool could be integrated into clinical workflow. Since 
many of our candidates preferred to receive the aid when visiting their outside 
cardiologist, the decision aid could initially be provided at the referring 
cardiologist’s office. However, a drawback in using the aid in the outside 
cardiologist’s office is that he or she may lack familiarity with device placement, 
perhaps introducing evidence that really is more program-specific. To offset this 
potential drawback, it might be appropriate to provide the aid once the patient is 
a candidate and is referred to a tertiary center, encouraging him or her to write 
down questions to bring to the tertiary center, where the decision aid can be used 
by a variety of professionals throughout the education or evaluation 
process. Social workers could go over the caregiver support section, for instance, 
and surgeons and cardiologists could go over the risk/benefit section of the aid. 
Limitations 
Acceptability of the tool was tested only among patients with sufficient cognitive 
functioning, as evaluated by the coordinator and social worker on the clinical 
team using guideposts provided in the Aid to Capacity Evaluation Tool (built by a 
Toronto Bioethics group; validated and reliable). While none of these patients 
were intubated or unconscious, many were still among the sickest inpatients 
hospitalized. We envision the aid being used with similar patient populations, but 
recognize that a wide range of cognitive functioning exists and not all patients will 
be able to attend to the tool for the 59 minutes it takes the average patients to 
thoroughly review it. For this reason, we purposefully built section tabs into the 
design for quick reference depending on the unique needs and concerns of 
patients and caregivers. To help ensure understanding in the cognitively 
impaired, we have supplementary videos in case the patient is too sick or tired to 
read. 
Another potential concern is whether the decision aid applies to both DT and BTT 
patients alike. After consulting with our expert panel, we concluded that because 
these designations are not static and often change throughout a patient’s 
treatment trajectory, the aid encompasses concerns for patients with either 
designation. 
An additional limitation is the small sample size and potential lack of 
generalizability to other patient samples with different knowledge needs, though 
the diversity of Houston’s patient population suggests that our findings likely 
encompass a variety of LVAD patient samples across the United States37.  
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Conclusion 
This study demonstrates the feasibility of developing a user-centered and 
clinically-informed decision aid for individuals facing the difficult decision of 
whether or not to get an LVAD. With the help of our patient partners, expert 
collaborators and experienced design team, we have developed an 
information-rich and aesthetically appealing aid that addresses commonalities 
in patient and caregiver questions and experiences in decision-making. The 
framework and steps presented here are theoretically grounded and practically 
generalizable to the development of other future decision aids.  
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